| A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and … O Shahin, GN Thalmann, C Rentsch, L Mazzucchelli, UE Studer The Journal of urology 169 (1), 96-100, 2003 | 289 | 2003 |
| Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer C Biot, CA Rentsch, JR Gsponer, FD Birkhäuser, H Jusforgues-Saklani, ... Science translational medicine 4 (137), 137ra72-137ra72, 2012 | 272 | 2012 |
| Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer JT Buijs, NV Henriquez, PGM Van Overveld, G Van Der Horst, I Que, ... Cancer research 67 (18), 8742-8751, 2007 | 251 | 2007 |
| BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo JT Buijs, CA Rentsch, G van der Horst, PGM van Overveld, A Wetterwald, ... The American journal of pathology 171 (3), 1047-1057, 2007 | 248 | 2007 |
| Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised … G Attard, L Murphy, NW Clarke, W Cross, RJ Jones, CC Parker, ... The lancet 399 (10323), 447-460, 2022 | 229 | 2022 |
| Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder cancer immunotherapy CA Rentsch, FD Birkhäuser, C Biot, JR Gsponer, A Bisiaux, C Wetterauer, ... European urology 66 (4), 677-688, 2014 | 210 | 2014 |
| The recombinant Bacille Calmette–Guérin vaccine VPM1002: ready for clinical efficacy testing NE Nieuwenhuizen, PS Kulkarni, U Shaligram, MF Cotton, CA Rentsch, ... Frontiers in immunology 8, 292743, 2017 | 191 | 2017 |
| ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence MF Chevalier, S Trabanelli, J Racle, B Salomé, V Cesson, D Gharbi, ... The Journal of clinical investigation 127 (8), 2916-2929, 2017 | 191 | 2017 |
| Urinary Interleukin-8 and 18 predict the response of superficial bladder cancer to intravesical therapy with bacillus Calmette-Guerin GN THALMANN, A SERMIER, C RENTSCH, K MÖHRLE, MG CECCHINI, ... The Journal of urology 164 (6), 2129-2133, 2000 | 174 | 2000 |
| Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases R Schwaninger, CA Rentsch, A Wetterwald, G van der Horst, ... The American journal of pathology 170 (1), 160-175, 2007 | 128 | 2007 |
| In vitro propagation and characterization of neoplastic stem/progenitor‐like cells from human prostate cancer tissue N Guzmán‐Ramírez, M Völler, A Wetterwald, M Germann, NA Cross, ... The Prostate 69 (15), 1683-1693, 2009 | 109 | 2009 |
| Toxicity and early treatment outcomes in low-and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy P Ghadjar, T Keller, CA Rentsch, B Isaak, F Behrensmeier, A Stroux, ... Brachytherapy 8 (1), 45-51, 2009 | 91 | 2009 |
| Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer C Le Magnen, L Bubendorf, CA Rentsch, C Mengus, J Gsponer, ... Clinical cancer research 19 (19), 5361-5371, 2013 | 83 | 2013 |
| Early development of human lymphomas in a prostate cancer xenograft program using triple knock‐out immunocompromised mice C Wetterauer, T Vlajnic, J Schüler, JR Gsponer, GN Thalmann, ... The Prostate 75 (6), 585-592, 2015 | 68 | 2015 |
| Adding celecoxib with or without zoledronic acid for hormone-naïve prostate cancer: long-term survival results from an adaptive, multiarm, multistage, platform, randomized … MD Mason, NW Clarke, ND James, DP Dearnaley, MR Spears, ... Journal of clinical oncology 35 (14), 1530, 2017 | 64 | 2017 |
| Improved detection of microbial ureteral stent colonisation by sonication G Bonkat, M Rieken, CA Rentsch, S Wyler, A Feike, J Schäfer, T Gasser, ... World journal of urology 29, 133-138, 2011 | 60 | 2011 |
| Deep clonal profiling of formalin fixed paraffin embedded clinical samples T Holley, E Lenkiewicz, L Evers, W Tembe, C Ruiz, JR Gsponer, ... PloS one 7 (11), e50586, 2012 | 57 | 2012 |
| Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naive prostate cancer and are elevated in castration … T Zellweger, S Stürm, S Rey, I Zlobec, JR Gsponer, CA Rentsch, ... Endocrine-related cancer 20 (3), 403-413, 2013 | 50 | 2013 |
| Differential expression of TGFβ‐stimulated clone 22 in normal prostate and prostate cancer CA Rentsch, MG Cecchini, R Schwaninger, M Germann, R Markwalder, ... International journal of cancer 118 (4), 899-906, 2006 | 46 | 2006 |
| Autonomous detection and classification of PI-RADS lesions in an MRI screening population incorporating multicenter-labeled deep learning and biparametric imaging: proof of concept DJ Winkel, C Wetterauer, MO Matthias, B Lou, B Shi, A Kamen, ... Diagnostics 10 (11), 951, 2020 | 44 | 2020 |
